Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Response of Host”

109 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 109 results

Not applicableActive Not RecruitingNCT06337955
What this trial is testing

Non Primary HCMV Infection: Natural History and Immune Response

Who this might be right for
Cytomegalovirus Infections
Fondazione IRCCS Policlinico San Matteo di Pavia 204
Not applicableStudy completedNCT01911143
What this trial is testing

A Retrospective, Blinded Validation of a Host-response Based Diagnostics

Who this might be right for
FeverRespiratory Tract InfectionsUrinary Tract Infections+2 more
MeMed Diagnostics Ltd. 600
Early research (Phase 1)Study completedNCT01674205
What this trial is testing

Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines

Who this might be right for
Influenza, Human
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableUnknownNCT01021098
What this trial is testing

Acute Respiratory Infection Consortium

Who this might be right for
Influenza
Henry M. Jackson Foundation for the Advancement of Military Medicine 2,018
Not applicableActive Not RecruitingNCT07316829
What this trial is testing

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Who this might be right for
Graft RejectionKidney TransplantationLung Transplantation+6 more
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Not applicableStudy completedNCT00468234
What this trial is testing

Validation of Biomarkers of Exposure and Host Response

Who this might be right for
Cigarette Smoker
University of Nebraska 60
Post-approval studies (Phase 4)Study completedNCT00537537
What this trial is testing

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B, Chronic
Novartis Pharmaceuticals 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05132166
What this trial is testing

Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease

Who this might be right for
Graft Vs Host Disease
University Health Network, Toronto 50
Testing effectiveness (Phase 2)Study completedNCT05210101
What this trial is testing

A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals

Who this might be right for
SARS CoV 2 Infection
Sophia Koo, M.D. 93
Not applicableStudy completedNCT05060939
What this trial is testing

SARS-CoV-2 Infection in COVID-19 Vaccinated Patients

Who this might be right for
COVID-19
Hospices Civils de Lyon 1,072
Testing effectiveness (Phase 2)Looking for participantsNCT06199427
What this trial is testing

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

Who this might be right for
Inborn Errors of Immunity
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100
Not applicableActive Not RecruitingNCT06838780
What this trial is testing

Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA

Who this might be right for
Gene ExpressionGene Expression ProfilingInfection+3 more
Chinese University of Hong Kong 192
Not applicableUnknownNCT04510623
What this trial is testing

Host Response Mediators in Coronavirus (COVID-19) Infection

Who this might be right for
COVID-19SARS-CoV2
University of British Columbia 500
Not applicableLooking for participantsNCT07374094
What this trial is testing

Clostridioides Difficile: Understanding Responses and Treatment Effects

Who this might be right for
Clostridioides Difficile Infection
Umeå University 200
Not applicableLooking for participantsNCT00128973
What this trial is testing

Evaluation of Patients With Immune Function Abnormalities

Who this might be right for
Chronic Granulomatous Disease (CGD)X-Linked Severe Combined Immune Deficiency (XSCID)Leukocyte Adhesion Deficiency 1 (LAD)+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 3,500
Post-approval studies (Phase 4)Study completedNCT02479074
What this trial is testing

The Utility of feNO in the Differential Diagnosis of Chronic Cough

Who this might be right for
Cough
Hull University Teaching Hospitals NHS Trust 49
Not applicableStudy completedNCT03744741
What this trial is testing

HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study

Who this might be right for
Respiratory Tract InfectionsUrinary Tract InfectionsSkin and Soft Tissue Infections+2 more
Inflammatix 585
Not applicableNot Yet RecruitingNCT06846645
What this trial is testing

Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis.

Who this might be right for
Single Cell Sequencing TechnologyGene Expression ProfilingGene Expression+7 more
Chinese University of Hong Kong 200
Testing effectiveness (Phase 2)Study completedNCT04795427
What this trial is testing

Study of Efficacy and Safety of CML-CP Patients Treated With Asciminib Versus Best Available Therapy, Previously Treated With 2 or More Tyrosine Kinase Inhibitors

Who this might be right for
Leukemia, Chronic Myelogenous
Novartis Pharmaceuticals 84
Early research (Phase 1)WithdrawnNCT04054752
What this trial is testing

Vaccine Response With NT-I7

Who this might be right for
Breast CarcinomaColorectal AdenocarcinomaBladder Carcinoma
National Cancer Institute (NCI)
Load More Results